Prostate Cancer
Research

Volume 1 Number 4
April 2013

Home > Disciplines > Publications > Prostate Cancer Research > Volume 1, Year 2013 > Number 4, April

CONTENTS

▼

DIAGNOSIS
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
PROGNOSIS
TREATMENT

DIAGNOSIS

▲

.

García JR, Ponce A, Canales M, Ayuso J, Moragas M, Soler M.
[Detection of second tumors in ¹¹C-choline PET/CT studies performed due to biochemical recurrence of prostate cancer.]
Rev Esp Med Nucl Imagen Mol. 2013 Mar 14. pii: S2253-654X(13)00010-3. Doi: 10.1016/j.remn.2013.01.007. [Epub ahead of print] Spanish.
Source | Full text | Similar articles

FOLLOW-UP, QUALITY OF LIFE

▲

.

Moinpour CM, Hayden KA, Unger JM, Thompson IM Jr, Redman MW, Canby-Hagino ED, Higgins BA, Sullivan JW, Lemmon D, Breslin S, Crawford ED, Southwest Oncology Group.
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
J Clin Oncol. 2008 Jan 1;26(1):112-20. doi: 10.1200/JCO.2006.10.4505.
Source | Full text | Similar articles

INTEGRATIVE MEDICINE

▲

.

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.
Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.
Source | Full text | Similar articles

PROGNOSIS

▲

.

Abdollah F, Boorjian S, Cozzarini C, Suardi N, Sun M, Fiorino C, di Muzio N, Karakiewicz PI, Montorsi F, Karnes RJ, Briganti A.
Survival Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiotherapy in Patients With Prostate Cancer: The Impact of Competing Causes of Mortality and Patient Stratification.
Eur Urol. 2013 Mar 13. pii: S0302-2838(13)00230-3. Doi: 10.1016/j.eururo.2013.03.006. [Epub ahead of print]
Source | Full text | Similar articles

.

Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML, Karnes RJ.
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.
Eur Urol. 2011 Jun;59(6):893-9. doi: 10.1016/j.eururo.2011.02.026. Epub 2011 Feb 22.
Source | Full text | Similar articles

.

Donovan MJ, Hamann S, Clayton M, Khan FM, Sapir M, Bayer-Zubek V, Fernandez G, Mesa-Tejada R, Teverovskiy M, Reuter VE, Scardino PT, Cordon-Cardo C.
Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.
J Clin Oncol. 2008 Aug 20;26(24):3923-9. doi: 10.1200/JCO.2007.15.3155.
Source | Full text | Similar articles

.

Ficarra V, Borghesi M, Suardi N, De Naeyer G, Novara G, Schatteman P, De Groote R, Carpentier P, Mottrie A.
Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
BJU Int. 2013 Mar 7. doi: 10.1111/bju.12001. [Epub ahead of print]
Source | Full text | Similar articles

.

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW.
Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.
J Clin Oncol. 2007 May 1;25(13):1765-71. DOI: 10.1200/JCO.2006.08.0572
Source | Full text | Similar articles

.

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW.
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
JAMA. 2005 Jul 27;294(4):433-9. doi:10.1001/jama.294.4.433
Source | Full text | Similar articles

.

Kim KH, Lim SK, Shin TY, Lee JY, Chung BH, Rha KH, Hong SJ.
Upgrading of Gleason score and prostate volume: a clinicopathological analysis.
BJU Int. 2013 Mar 4. doi: 10.1111/j.1464-410X.2013.11799.x. [Epub ahead of print]
Source | Full text | Similar articles

.

Nepple KG, Stephenson AJ, Kallogjeri D, Michalski J, Grubb RL 3rd, Strope SA, Haslag-Minoff J, Piccirillo JF, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Kibel AS.
Mortality After Prostate Cancer Treatment with Radical Prostatectomy, External-Beam Radiation Therapy, or Brachytherapy in Men Without Comorbidity.
Eur Urol. 2013 Mar 13. pii: S0302-2838(13)00229-7. doi: 10.1016/j.eururo.2013.03.005. [Epub ahead of print]
Source | Full text | Similar articles

.

Pierorazio PM, Walsh PC, Partin AW, Epstein JI.
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.
BJU Int. 2013 May;111(5):753-60. doi: 10.1111/j.1464-410X.2012.11611.x. Epub 2013 Mar 6.
Source | Full text | Similar articles

.

Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC.
Natural history of progression after PSA elevation following radical prostatectomy.
JAMA. 1999 May 5;281(17):1591-7. doi:10.1001/jama.281.17.1591
Source | Full text | Similar articles

.

Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H.
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Mayo Clin Proc. 2001 Jun;76(6):576-81. DOI: https://doi.org/10.4065/76.6.576
Source | Full text | Similar articles

.

Røder MA, Brasso K, Christensen IJ, Johansen J, Langkilde NC, Hvarness H, Carlsson S, Jakobsen H, Borre M, Iversen P.
Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study.
BJU Int. 2013 Mar 15. doi: 10.1111/bju.12065. [Epub ahead of print]
Source | Full text | Similar articles

.

Rogers CG, Khan MA, Craig Miller M, Veltri RW, Partin AW.
Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
Cancer. 2004 Dec 1;101(11):2549-56. https://doi.org/10.1002/cncr.20637
Source | Full text | Similar articles

.

Schiavina R, Borghesi M, Fiorentino M, Brunocilla E, Manferrari F, Vagnoni V, Martorana G.
Identification of prostate cancer risk categories according to surgical margins status, pathological stage and Gleason score.
Int J Urol. 2013 Mar 21. doi: 10.1111/iju.12124. [Epub ahead of print]
Source | Full text | Similar articles

.

Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A, Huddart RA, Dearnaley DP, Parker CC.
Medium-term Outcomes of Active Surveillance for Localised Prostate Cancer.
Eur Urol. 2013 Feb 18. pii: S0302-2838(13)00132-2. Doi: 10.1016/j.eururo.2013.02.020. [Epub ahead of print]
Source | Full Text | Similar articles

.

Shariat SF, Walz J, Roehrborn CG, Zlotta AR, Perrotte P, Suardi N, Saad F, Karakiewicz PI.
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
J Clin Oncol. 2008 Mar 20;26(9):1526-31. doi: 10.1200/JCO.2007.12.4669.
Source | Full text | Similar articles

.

Tomaszewski JJ, Chen YF, Bertolet M, Ristau BT, Woldemichael E, Nelson JB.
Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
Urology. 2013 May;81(5):992-7. doi: 10.1016/j.urology.2012.10.080. Epub 2013 Mar 1.
Source | Full text | Similar articles

.

Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC.
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
JAMA. 2008 Jun 18;299(23):2760-9. doi: 10.1001/jama.299.23.2760.
Source | Full text | Similar articles

.

Wright JL, Plymate SR, Porter MP, Gore JL, Lin DW, Hu E, Zeliadt SB.
Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer.
Prostate Cancer Prostatic Dis. 2013 Mar 5. doi: 10.1038/pcan.2013.5. [Epub ahead of print]
Source | Full text | Similar articles

.

Yeung VH, Chiu Y, Yu SS, Au WH, Chan SW.
Are preoperative Kattan and Stephenson nomograms predicting biochemical recurrence after radical prostatectomy applicable in the chinese population?
ScientificWorldJournal. 2013;2013:506062. doi: 10.1155/2013/506062. Epub 2013 Mar 5.
Source | Full text | Similar articles

TREATMENT

▲

.

Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Passoni N, Fossati N, Sun M, Dell'oglio P, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A.
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center.
Ann Oncol. 2013 Mar 18. https://doi.org/10.1093/annonc/mdt120. [Epub ahead of print]
Source | Full text | Similar articles

.

Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.
Radiat Oncol. 2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.
Source | Full text | Similar articles

.

Enel C, Matte A, Berchi C, Binquet C, Cormier L, Lejeune C.
Prostate cancer: how do patients choose their treatment?
Bull Cancer. 2013 Mar;100(3):191-199. https://doi.org/10.1684/bdc.2013.1707
Source | Full text | Similar articles

.

Nabhan M, Kim SP, Shah ND, Bagniewski SM, Shi Q, Karnes RJ, Weight CJ, Davis BJ, Kohli M, Tilburt JC.
The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.
Mayo Clin Proc. 2012 Jun;87(6):540-7. doi: 10.1016/j.mayocp.2012.01.017.
Source | Full text | Similar articles

.

Nakabayashi M, Xie W, Buckle G, Bubley G, Ernstoff MS, Walsh W, Morganstern DE, Kantoff PW, Taplin ME.
Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.
Urology. 2013 Mar;81(3):611-6. doi: 10.1016/j.urology.2012.12.025.
Source | Full text | Similar articles

.

Oliai C, Lanciano R, Sprandio B, Yang J, Lamond J, Arrigo S, Good M, Mooreville M, Garber B, Brady LW.
Stereotactic body radiation therapy for the primary treatment of localized prostate cancer.
J Radiat Oncol. 2013 Mar;2(1):63-70. Epub 2012 Sep 12.
Source | Full text | Similar articles

.

Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR.
How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
BJU Int. 2013 Mar 4. doi: 10.1111/j.1464-410X.2012.11493.x. [Epub ahead of print]
Source | Full text | Similar articles

.

Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM.
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA. 2004 Mar 17;291(11):1325-32. doi:10.1001/jama.291.11.1325
Source | Full text | Similar articles

.

Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED; SWOG 8794.
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.
J Clin Oncol. 2007 Jun 1;25(16):2225-9.
Source | Full text | Similar articles

bottom

▲